StockDocs
Project by Matthew Castle Please send feedback to matthewgcastle@gmail.com
VYGR

Voyager Therapeutics, Inc.

VYGR Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗
$3.00
-0.13 -4.15%

Key statistics

from XBRL data in SEC filings
Market cap
$181M
Revenue (TTM)
$36.5M
Net income (TTM)
-$117M
EPS (TTM)
$-1.98
P/E ratio
Dividend yield
Free cash flow
-$135M
Cash
$43.3M
Total assets
$219M
Gross margin
52-week range
$2.88 – $5.55

Recent SEC filings

40 most recent
Annual, quarterly & current reports
8-K Other events Jul 13, 2026 8-K Amended charter or bylaws; Shareholder vote results Jun 10, 2026 8-K Other events Jun 1, 2026 8-K Results of operations (earnings release) May 7, 2026 10-Q Quarter ended 2026-03-31 May 7, 2026 8-K Director or officer change Apr 21, 2026 8-K Results of operations (earnings release) Mar 9, 2026 10-K Fiscal year ended 2025-12-31 Mar 9, 2026 8-K Director or officer change; Other events Feb 12, 2026 8-K Regulation FD disclosure Jan 8, 2026 10-Q Quarter ended 2025-09-30 Nov 10, 2025 8-K Results of operations (earnings release) Nov 10, 2025 8-K Regulation FD disclosure Sep 2, 2025 10-Q Quarter ended 2025-06-30 Aug 6, 2025 8-K Results of operations (earnings release) Aug 6, 2025 8-K Director or officer change; Shareholder vote results Jun 5, 2025 10-Q Quarter ended 2025-03-31 May 6, 2025 8-K Results of operations (earnings release) May 6, 2025 10-K Fiscal year ended 2024-12-31 Mar 11, 2025 8-K Results of operations (earnings release) Mar 11, 2025 8-K Other events Feb 11, 2025 10-Q Quarter ended 2024-09-30 Nov 12, 2024 8-K Results of operations (earnings release) Nov 12, 2024 8-K Entered a material agreement Sep 5, 2024 10-Q Quarter ended 2024-06-30 Aug 6, 2024 8-K Results of operations (earnings release) Aug 6, 2024 8-K Director or officer change Jun 13, 2024 8-K Shareholder vote results Jun 6, 2024 8-K Other events May 16, 2024 10-Q Quarter ended 2024-03-31 May 13, 2024 8-K Results of operations (earnings release) May 13, 2024 8-K Director or officer change Apr 2, 2024 8-K Other events Mar 13, 2024 10-K Fiscal year ended 2023-12-31 Feb 28, 2024 8-K Results of operations (earnings release) Feb 28, 2024 8-K Entered a material agreement; Other events Jan 8, 2024 8-K Entered a material agreement; Results of operations (earnings release); Unregistered sale of equity; Other events Jan 2, 2024 8-K Other events Dec 6, 2023 10-Q Quarter ended 2023-09-30 Nov 6, 2023 8-K Results of operations (earnings release) Nov 6, 2023